FOXO Technologies Inc. (FOXOD)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Healthcare	16.09M	4.02M	-	-	-
Healthcare Growth	300.26%	-	-	-	-
Life Science Services	252.50K	-	-	-	-
Labs	13.92K	32.64K	145.29K	-	-
Labs Growth	-57.34%	-77.53%	-	-	-
Corporate and Other	15.09K	-	-	-	-
FOXO Labs	-	-	-	483.00K	85.00K
FOXO Labs Growth	-	-	-	468.24%	269.57%
FOXO Life	-	-	-	28.00K	35.00K
FOXO Life Growth	-	-	-	-20.00%	-12.50%
Total	16.37M	4.05M	145.29K	511.00K	120.00K
Total Growth	303.98%	2688.61%	-71.57%	325.83%	90.48%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
United States	16.37M	4.05M	145.29K	511.00K	120.00K
United States Growth	303.98%	2688.61%	-71.57%	325.83%	90.48%
Total	16.37M	4.05M	145.29K	511.00K	120.00K
Total Growth	303.98%	2688.61%	-71.57%	325.83%	90.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error